Basel Medical Group Ltd Ordinary Shares (BMGL) Financials

$4.19

$-0.40 (-8.71%)

As on 22-Sep-2026 16:12EDT

Market cap

$7 Mln

Revenue (TTM)

$-- Mln

P/E Ratio

--

P/B Ratio

1.4

Div. Yield

0 %

Annual
Quarterly

Income Statement (S$ Mln)	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15
Operating Revenue	11.32	10.05	9.70	10.66	--	--
Cost of Revenue	2.53	2.25	2.34	2.18	--	--
Gross Profit	8.79	7.80	7.36	8.48	--	--
Operating Expenses	10.98	5.61	5.36	6.01	--	--
Operating Profit (EBIT)	-2.18	2.20	2.00	2.47	--	--
Other Income	--	--	--	--	--	--
Profit before Tax	-12.51	2.40	2.13	2.39	--	--
Provision for Tax	-0.42	0.33	0.35	0.41	--	--
Profit after Tax (Net Income)	-12.09	2.07	1.78	1.98	--	--
Minority Interest	0.00	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	--

Liabilities (S$ Mln)	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15
Shareholder's Funds	4.86	7.56	5.49	3.71	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1.30	1.58	3.42	5.95	--	--
Current Liabilities	10.69	7.16	6.47	7.19	--	--
Total Liabilities	16.85	16.31	15.38	16.85	--	--

Assets (S$ Mln)	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15
Non-Current Assets	3.74	0.13	0.61	1.18	--	--
Current Assets	13.12	16.17	14.77	15.67	--	--
Total Assets	16.85	16.31	15.38	16.85	--	--
Total Debt*	3.42	4.29	7.21	10.15	--	--
Net Current Assets	2.43	9.01	8.31	8.47	--	--

Cashflow (S$ Mln)	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15
Cash From Operating Activities	-4.34	2.51	2.60	2.79	--	--
Cash Flow from Investing Activities	-11.04	-0.01	-0.01	-0.09	--	--
Cash from Financing Activities	16.91	-1.77	-2.94	-12.92	--	--
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15
Adjusted EPS (S$)	--	--	--	--	--	--
Cash EPS (S$)	--	--	--	--	--	--
Adjusted Book Value (S$)	--	--	--	--	--	--
Dividend per Share (S$)	--	--	--	--	--	--
Cash Flow per Share (S$)	--	--	--	--	--	--
Free Cash Flow per Share (S$)	--	--	--	--	--	--

Profitability Ratios	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15
ROCE (%)	-120.08	16.88	13.43	--	--	--
ROE (%)	-194.61	31.77	38.79	--	--	--
ROA (%)	-72.90	13.08	11.07	--	--	--
EBIT Margin (%)	-108.67	25.68	24.43	25.40	--	--
Net Margin (%)	-106.78	20.62	18.38	18.56	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15
Revenue Growth (%)	0.13	0.04	-0.09	--	--	--
EBIT Growth (%)	-576.66	8.89	-12.45	--	--	--
Net Profit Growth (%)	-683.15	16.23	-9.84	--	--	--
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Solvency Ratios	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15
Debt to Equity	0.70	0.57	1.31	2.74	--	--
Short term debt to equity ratio	0.44	0.36	0.69	1.13	--	--
Current Ratio	1.23	2.26	2.28	2.18	--	--
Quick Ratio	1.19	2.25	2.27	2.17	--	--
Interest Coverage	-60.32	14.64	9.93	8.44	--	--

Operating Efficiency Ratios	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15
Debtors to sales (%)	22.04	123.81	137.38	130.26	--	--
Asset Turnover	0.68	0.63	0.60	--	--	--
Receivable days	241.01	468.28	512.24	475.78	--	--
Inventory Days	32.41	13.54	12.85	11.71	--	--
Payable days	211.58	186.32	198.75	180.88	--	--
Cash Conversion Cycle	61.84	295.50	326.34	306.61	--	--